TickerFacts.

Company research / KIDS

Orthopediatrics Corp (KIDS)

Build a valuation ↗↓ Download CSV

SEC name ORTHOPEDIATRICS CORP · CIK 0001425450 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Orthopediatrics Corp reported revenue of $236.35M. Revenue grew 15.4% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $252.72M.

Key ratios (year ended 2025-12-31)

73.1%
Gross margin
-16.6%
Operating margin
-16.8%
Net margin
-11.4%
Return on year-end equity
15.4%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-11

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$252.72M$236.35M$204.73M$148.73M$122.29M$98.05M$71.08M$72.55M$57.56M$45.62M$37.30M
Cost of Revenue$66.59M$63.69M$56.13M$37.48M$31.63M$24.65M$16.05M$17.93M$14.88M$11.17M$10.93M
Gross Profit$186.14M$172.66M$148.60M$111.25M$90.66M$73.40M$55.03M$54.62M$42.68M$34.45M$26.37M
R&D Expense$9.15M$9.10M$11.03M$10.89M$8.45M$5.54M$5.27M$5.75M$4.73M$3.42M$2.22M
Operating Income-$30.00M-$39.24M-$35.01M-$26.75M-$25.40M-$18.02M-$26.75M-$9.08M-$9.55M-$6.47M-$6.13M
Depreciation & Amortization$22.33M$21.12M$19.08M$17.39M$13.10M$10.68M$8.01M$4.67M$2.89M$2.40M$1.90M
EBITDA-$7.67M-$18.12M-$15.93M-$9.37M-$12.30M-$7.34M-$18.75M-$4.41M-$6.66M-$4.07M-$4.22M
Net Income-$39.73M-$39.65M-$37.82M-$20.97M$1.26M-$16.26M-$32.94M-$13.73M-$12.03M-$8.93M-$6.57M
EPS (Diluted)n/a-$1.69-$1.64-$0.92$0.06-$0.84-$1.82-$0.94n/an/an/a
Total Assets$511.39M$508.63M$473.21M$438.75M$427.73M$304.27M$320.41M$182.15M$112.11M$82.30M$30.68M
Total Liabilities$167.77M$162.03M$118.64M$61.72M$49.08M$78.91M$85.64M$39.79M$30.37M$34.81M$24.68M
Long-Term Debt$105.75M$106.01M$77.48M$11.06M$907.0K$1.04M$1.18M$26.19M$21.27M$25.45M$17.54M
Shareholders' Equity$343.61M$346.60M$354.57M$377.02M$378.65M$225.37M$234.77M$142.36M$81.73M$47.49M-$65.31M
Cash & Equivalents$17.00M$19.56M$43.82M$31.05M$8.99M$7.64M$28.76M$70.78M$60.69M$42.58M$1.61M
Operating Cash Flow$7.41M-$4.85M-$27.05M-$27.05M-$21.77M-$13.06M-$18.53M-$17.77M-$15.58M-$7.22M-$1.12M
Capital Expenditures$9.24M$11.11M$14.26M$16.88M$10.03M$8.10M$10.50M$11.82M$5.25M$5.21M$4.35M
Free Cash Flow-$1.83M-$15.96M-$41.31M-$43.92M-$31.80M-$21.17M-$29.03M-$29.59M-$20.84M-$12.42M-$5.47M
Dividends Paidn/an/an/an/an/an/an/a$0$0$5.96M$0
Shares Outstandingn/a25.09M24.22M23.38M22.88M19.68M19.56M16.72M14.54M12.62M2.42M
Weighted Average Diluted Sharesn/a23.46M23.08M22.68M20.95M19.27M18.06M14.62Mn/an/an/a
EPS (Basic)n/a-$1.69-$1.64-$0.92$0.06-$0.84-$1.82-$0.94n/an/an/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView